SCHEMBL3719216

SCHEMBL3719216

COc1ccc(C2(O)CCN(C(=O)OCc3ccccc3)CC2)cn1.[Li]CCCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
OPRD1 P41143 7/20 0.42
OPRK1 P41145 6/20 0.42
CCR1 P32246 1/20 0.42
NOS2 P35228 1/20 0.41
CCR5 P51681 2/20 0.41
OPRM1 P35372 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CHRM4 P08173 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
APP P05067 1/20 0.38
SCN5A Q14524 1/20 0.38
SCN9A Q15858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2264503 0.92 HDAC3 (0.48) HDAC3HDAC1HDAC2HDAC6OPRD1
SCHEMBL751730 0.84 OPRD1 (0.47) HDAC3HDAC1HDAC2HDAC6OPRD1
SCHEMBL6538566 0.76 DRD2 (0.51) OPRD1OPRK1CCR1NOS2CCR5
SCHEMBL8315425 0.76 OPRD1 (0.54) OPRD1OPRK1CCR1NOS2OPRM1
SCHEMBL14922381 0.75 CHRM4 (0.50) HDAC3HDAC1HDAC2HDAC6OPRD1
SCHEMBL3662100 0.75 LMNA (0.43) OPRD1OPRK1OPRM1MEN1KMT2A
SCHEMBL7556949 0.74 CHRM4 (0.61) HDAC3HDAC1HDAC2HDAC6OPRD1
SCHEMBL6043019 0.74 GPR119 (0.52) OPRD1OPRK1CCR1MEN1KMT2A
SCHEMBL2265088 0.73 MEN1 (0.69) HDAC3HDAC1HDAC2HDAC6OPRD1
SCHEMBL751049 0.73 OPRD1 (0.53) HDAC3HDAC1HDAC2HDAC6OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2235010-A1 BICYCLIC DERIVATIVES FOR USE IN THE TREATMENT OF ANDROGEN RECEPTOR ASSOCIATED CONDITIONS AstraZeneca AB (SE) 2010-10-06 EP disclosed
WO-2009081197-A1 BICYCLIC DERIVATIVES FOR USE IN THE TREATMENT OF ANDROGEN RECEPTOR ASSOCIATED CONDITIONS ASTRAZENECA AB (SE) 2009-07-02 WO disclosed